APO RESEARCH · REPORT
10-Deacetylbaccatin III
10-Deacetylbaccatin III is a taxane-scaffold chemical supplied as an identified research or manufacturing input.
Product & engineering
Understand the product.
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 10-Deacetylbaccatin III?
Chemical identity, substitution pattern, assay and related impurities define the supplied material. The named chemical category does not establish a finished formulation’s compatibility, end-use approval or performance; those depend on the actual grade and application.
Technical reading
Selected research
Market Structure
Global 10-Deacetylbaccatin III Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Global 10-Deacetylbaccatin III key players include SM Herbals, Alchem International, Indena, etc. Global top three manufacturers hold a share over 50%.
China is the largest market, with a share over 35%, followed by United States and Europe, both have a share over 50 percent.
Read the full market overview
In terms of product, ≥98.0% is the largest segment, with a share over 85%. And in terms of application, the largest application is Production of Docetaxel, followed by Production of Paclitaxel, etc.
The report provides an overview of the global 10-Deacetylbaccatin III market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 10-Deacetylbaccatin III and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 10-Deacetylbaccatin III sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 10-Deacetylbaccatin III market size, projected growth trends, production technologies, key applications, and end-use industries.
10-Deacetylbaccatin III Segment by Company
SM Herbals
Alchem International
Indena
South Pharmaceutical
HAOXUAN
Yuannan Hande
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Hainan Yew Pharmaceutical
10-Deacetylbaccatin III Segment by Type
Above 95%
Above 98.0%
Others
10-Deacetylbaccatin III Segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
10-Deacetylbaccatin III Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatin III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatin III and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatin III.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 10-Deacetylbaccatin III market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 10-Deacetylbaccatin III industry.
Chapter 3: Detailed analysis of 10-Deacetylbaccatin III market competition landscape. Including 10-Deacetylbaccatin III manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of 10-Deacetylbaccatin III by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of 10-Deacetylbaccatin III in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 95%
- Above 98.0%
- Others
Applications
- Production of Docetaxel
- Production of Paclitaxel
- Others
Companies covered
- SM Herbals
- Alchem International
- Indena
- South Pharmaceutical
- HAOXUAN
- Yuannan Hande
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Hainan Yew Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 10-Deacetylbaccatin III Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global 10-Deacetylbaccatin III Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global 10-Deacetylbaccatin III Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global 10-Deacetylbaccatin III Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global 10-Deacetylbaccatin III Market Dynamics
- 2.1 10-Deacetylbaccatin III Industry Trends
- 2.2 10-Deacetylbaccatin III Industry Drivers
- 2.3 10-Deacetylbaccatin III Industry Opportunities and Challenges
- 2.4 10-Deacetylbaccatin III Industry Restraints
3 10-Deacetylbaccatin III Market by Manufacturers
- 3.1 Global 10-Deacetylbaccatin III Production Value by Manufacturers (2021-2026)
- 3.2 Global 10-Deacetylbaccatin III Production by Manufacturers (2021-2026)
- 3.3 Global 10-Deacetylbaccatin III Average Price by Manufacturers (2021-2026)
- 3.4 Global 10-Deacetylbaccatin III Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 10-Deacetylbaccatin III Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 10-Deacetylbaccatin III Manufacturers, Product Type & Application
- 3.7 Global 10-Deacetylbaccatin III Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 10-Deacetylbaccatin III Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 10-Deacetylbaccatin III Players Market Share by Production Value in 2025
- 3.8.3 2025 10-Deacetylbaccatin III Tier 1, Tier 2, and Tier 3
4 10-Deacetylbaccatin III Market by Type
- 4.1 10-Deacetylbaccatin III Type Introduction
- 4.1.1 Above 95%
- 4.1.2 Above 98.0%
- 4.1.3 Others
- 4.2 Global 10-Deacetylbaccatin III Production by Type
- 4.2.1 Global 10-Deacetylbaccatin III Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 10-Deacetylbaccatin III Production by Type (2021-2032)
- 4.2.3 Global 10-Deacetylbaccatin III Production Market Share by Type (2021-2032)
- 4.3 Global 10-Deacetylbaccatin III Production Value by Type
- 4.3.1 Global 10-Deacetylbaccatin III Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 10-Deacetylbaccatin III Production Value by Type (2021-2032)
- 4.3.3 Global 10-Deacetylbaccatin III Production Value Market Share by Type (2021-2032)
5 10-Deacetylbaccatin III Market by Application
- 5.1 10-Deacetylbaccatin III Application Introduction
- 5.1.1 Production of Docetaxel
- 5.1.2 Production of Paclitaxel
- 5.1.3 Others
- 5.2 Global 10-Deacetylbaccatin III Production by Application
- 5.2.1 Global 10-Deacetylbaccatin III Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 10-Deacetylbaccatin III Production by Application (2021-2032)
- 5.2.3 Global 10-Deacetylbaccatin III Production Market Share by Application (2021-2032)
- 5.3 Global 10-Deacetylbaccatin III Production Value by Application
- 5.3.1 Global 10-Deacetylbaccatin III Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 10-Deacetylbaccatin III Production Value by Application (2021-2032)
- 5.3.3 Global 10-Deacetylbaccatin III Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 SM Herbals
- 6.1.1 SM Herbals Company Information
- 6.1.2 SM Herbals Business Overview
- 6.1.3 SM Herbals 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.1.4 SM Herbals 10-Deacetylbaccatin III Product Portfolio
- 6.1.5 SM Herbals Recent Developments
- 6.2 Alchem International
- 6.2.1 Alchem International Company Information
- 6.2.2 Alchem International Business Overview
- 6.2.3 Alchem International 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.2.4 Alchem International 10-Deacetylbaccatin III Product Portfolio
- 6.2.5 Alchem International Recent Developments
- 6.3 Indena
- 6.3.1 Indena Company Information
- 6.3.2 Indena Business Overview
- 6.3.3 Indena 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.3.4 Indena 10-Deacetylbaccatin III Product Portfolio
- 6.3.5 Indena Recent Developments
- 6.4 South Pharmaceutical
- 6.4.1 South Pharmaceutical Company Information
- 6.4.2 South Pharmaceutical Business Overview
- 6.4.3 South Pharmaceutical 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.4.4 South Pharmaceutical 10-Deacetylbaccatin III Product Portfolio
- 6.4.5 South Pharmaceutical Recent Developments
- 6.5 HAOXUAN
- 6.5.1 HAOXUAN Company Information
- 6.5.2 HAOXUAN Business Overview
- 6.5.3 HAOXUAN 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.5.4 HAOXUAN 10-Deacetylbaccatin III Product Portfolio
- 6.5.5 HAOXUAN Recent Developments
- 6.6 Yuannan Hande
- 6.6.1 Yuannan Hande Company Information
- 6.6.2 Yuannan Hande Business Overview
- 6.6.3 Yuannan Hande 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.6.4 Yuannan Hande 10-Deacetylbaccatin III Product Portfolio
- 6.6.5 Yuannan Hande Recent Developments
- 6.7 Sai Phytoceuticals
- 6.7.1 Sai Phytoceuticals Company Information
- 6.7.2 Sai Phytoceuticals Business Overview
- 6.7.3 Sai Phytoceuticals 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.7.4 Sai Phytoceuticals 10-Deacetylbaccatin III Product Portfolio
- 6.7.5 Sai Phytoceuticals Recent Developments
- 6.8 Sarv Biolabs Pvt
- 6.8.1 Sarv Biolabs Pvt Company Information
- 6.8.2 Sarv Biolabs Pvt Business Overview
- 6.8.3 Sarv Biolabs Pvt 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.8.4 Sarv Biolabs Pvt 10-Deacetylbaccatin III Product Portfolio
- 6.8.5 Sarv Biolabs Pvt Recent Developments
- 6.9 Aphios
- 6.9.1 Aphios Company Information
- 6.9.2 Aphios Business Overview
- 6.9.3 Aphios 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.9.4 Aphios 10-Deacetylbaccatin III Product Portfolio
- 6.9.5 Aphios Recent Developments
- 6.10 Hainan Yew Pharmaceutical
- 6.10.1 Hainan Yew Pharmaceutical Company Information
- 6.10.2 Hainan Yew Pharmaceutical Business Overview
- 6.10.3 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Production, Value and Gross Margin (2021-2026)
- 6.10.4 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Product Portfolio
- 6.10.5 Hainan Yew Pharmaceutical Recent Developments
7 Global 10-Deacetylbaccatin III Production by Region
- 7.1 Global 10-Deacetylbaccatin III Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global 10-Deacetylbaccatin III Production by Region (2021-2032)
- 7.2.1 Global 10-Deacetylbaccatin III Production by Region (2021-2026)
- 7.2.2 Global 10-Deacetylbaccatin III Production Forecast by Region (2027-2032)
- 7.3 Global 10-Deacetylbaccatin III Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global 10-Deacetylbaccatin III Production Value by Region (2021-2032)
- 7.4.1 Global 10-Deacetylbaccatin III Production Value by Region (2021-2026)
- 7.4.2 Global 10-Deacetylbaccatin III Production Value by Region (2027-2032)
- 7.5 Global 10-Deacetylbaccatin III Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America 10-Deacetylbaccatin III Production Value (2021-2032)
- 7.6.2 Europe 10-Deacetylbaccatin III Production Value (2021-2032)
- 7.6.3 Asia-Pacific 10-Deacetylbaccatin III Production Value (2021-2032)
- 7.6.4 South America 10-Deacetylbaccatin III Production Value (2021-2032)
- 7.6.5 Middle East & Africa 10-Deacetylbaccatin III Production Value (2021-2032)
8 Global 10-Deacetylbaccatin III Consumption by Region
- 8.1 Global 10-Deacetylbaccatin III Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global 10-Deacetylbaccatin III Consumption by Region (2021-2032)
- 8.2.1 Global 10-Deacetylbaccatin III Consumption by Region (2021-2026)
- 8.2.2 Global 10-Deacetylbaccatin III Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa 10-Deacetylbaccatin III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa 10-Deacetylbaccatin III Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 10-Deacetylbaccatin III Value Chain Analysis
- 9.1.1 10-Deacetylbaccatin III Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 10-Deacetylbaccatin III Production Mode & Process
- 9.2 10-Deacetylbaccatin III Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 10-Deacetylbaccatin III Distributors
- 9.2.3 10-Deacetylbaccatin III Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst